Emerging reality
Targeted Regenerative Aging
Converging research points to actionable molecular and cellular targets that could reverse or slow tissue and brain aging through targeted therapies.
11 stories · 11 in the last two weeks
Elevated autophagy markers in older tissues often signal stalled cleanup, not better cellular health.
nature.com · 9 sources
Restoring Menin in the hypothalamus reverses mouse brain aging — could Menin-targeted therapy reverse human cognitive decline?
pubmed.ncbi.nlm.nih.gov · 7 sources
Lacosamide’s osteoarthritis benefits point to Nav1.7, but could its pain and cartilage effects instead run through CRMP2-driven pathways?
pubmed.ncbi.nlm.nih.gov · 5 sources
HIIT may uniquely preserve lean muscle during fat loss in healthy older adults, proponents of a recent six‑month trial argue.
unisc.edu.au · 7 sources
P2X7 inhibitors for Alzheimer's and Parkinson's — promising preclinical target stalled by translation.
exa.ai · 8 sources
15-PGDH inhibitors could unlock real knee cartilage regeneration and make many joint replacements avoidable, proponents argue.
med.stanford.edu · 6 sources
Imidazole propionate-producing gut bacteria may be driving accelerated brain aging, some researchers argue.
link.springer.com · 9 sources
Plasma imidazole propionate (ImP) is a contributing cause of Alzheimer’s pathology — or so recent genetic and animal studies suggest.
nature.com · 6 sources
Leucine may protect mitochondrial proteins and raise respiration in stressed tissues.
preview-www.nature.com · 6 sources
Specific BNST neuron subtypes are the hidden switch that turns cannabis into anxiety during stress.
pmc.ncbi.nlm.nih.gov · 9 sources
Increasing hepatic UBE2N activity could block progression from fatty liver to MASH, proponents of the pathway argue.
nrf2.com · 4 sources